Quantification of bulk lipid species in human platelets and their thrombin-induced release.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 04 2023
Historique:
received: 29 09 2022
accepted: 06 04 2023
medline: 18 4 2023
entrez: 15 4 2023
pubmed: 16 4 2023
Statut: epublish

Résumé

Lipids play a central role in platelet physiology. Changes in the lipidome have already been described for basal and activated platelets. However, quantitative lipidomic data of platelet activation, including the released complex lipids, are unavailable. Here we describe an easy-to-use protocol based on flow-injection mass spectrometry for the quantitative analysis of bulk lipid species in basal and activated human platelets and their lipid release after thrombin activation. We provide lipid species concentrations of 12 healthy human donors, including cholesteryl ester (CE), ceramide (Cer), free cholesterol (FC), hexosylceramide (HexCer), lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylserine (PS), sphingomyelin (SM) and triglycerides (TG). The assay exhibited good technical repeatability (CVs < 5% for major lipid species in platelets). Except for CE and TG, the inter-donor variability of the majority of lipid species concentrations in platelets was < 30% CV. Balancing of concentrations revealed the generation of LPC and loss of TG. Changes in lipid species concentrations indicate phospholipase-mediated release of arachidonic acid mainly from PC, PI, and PE but not from PS. Thrombin induced lipid release was mainly composed of FC, PS, PC, LPC, CE, and TG. The similarity of the released lipidome with that of plasma implicates that lipid release may originate from the open-canalicular system (OCS). The repository of lipid species concentrations determined with this standardized platelet release assay contribute to elucidating the physiological role of platelet lipids and provide a basis for investigating the platelet lipidome in patients with hemorrhagic or thrombotic disorders.

Identifiants

pubmed: 37061580
doi: 10.1038/s41598-023-33076-4
pii: 10.1038/s41598-023-33076-4
pmc: PMC10105721
doi:

Substances chimiques

Thrombin EC 3.4.21.5
Triglycerides 0
Cholesterol 97C5T2UQ7J
Lecithins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6154

Informations de copyright

© 2023. The Author(s).

Références

Biochim Biophys Acta. 2008 Oct;1781(10):655-64
pubmed: 18723117
Blood. 1989 Nov 1;74(6):1983-8
pubmed: 2804343
J Lipid Res. 2021;62:100050
pubmed: 33600775
PLoS One. 2013 Nov 07;8(11):e79736
pubmed: 24244551
J Biol Chem. 1980 Mar 10;255(5):1790-2
pubmed: 6766454
Sci Rep. 2016 Jun 14;6:27710
pubmed: 27295977
Anal Chim Acta. 2020 Jan 15;1094:57-69
pubmed: 31761048
J Biol Chem. 1981 Jan 25;256(2):579-82
pubmed: 7451460
Biochim Biophys Acta. 2004 Nov 8;1686(1-2):108-17
pubmed: 15522827
Cardiovasc Res. 2022 Jun 29;118(8):1904-1916
pubmed: 34323932
Circ Res. 2014 Mar 28;114(7):1185-203
pubmed: 24677238
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
Cell Metab. 2016 May 10;23(5):930-44
pubmed: 27133131
J Lipid Res. 1999 Aug;40(8):1539-46
pubmed: 10428992
Blood. 2018 Aug 2;132(5):e1-e12
pubmed: 29784642
J Lipid Res. 2008 May;49(5):1137-46
pubmed: 18281723
J Biol Chem. 1981 Feb 25;256(4):1522-4
pubmed: 7462211
J Biol Chem. 1983 Feb 25;258(4):2461-7
pubmed: 6401733
J Biol Chem. 1987 Feb 15;262(5):2262-9
pubmed: 3102469
J Pharm Biomed Anal. 2021 Oct 25;205:114301
pubmed: 34391135
J Clin Invest. 1980 Aug;66(2):275-83
pubmed: 7400315
Clin Chem. 2002 Dec;48(12):2217-24
pubmed: 12446479
J Biol Chem. 2011 Jul 1;286(26):23247-53
pubmed: 21561861
Biochemistry. 1996 May 7;35(18):5822-32
pubmed: 8639543
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Aug;1864(8):1168-1182
pubmed: 30980920
Anal Chem. 2020 Aug 18;92(16):10966-10970
pubmed: 32672443
Platelets. 2018 Jun;29(4):319-325
pubmed: 29442528
J Lipid Res. 2009 Mar;50(3):574-585
pubmed: 18832345
Int J Mol Sci. 2022 Jul 28;23(15):
pubmed: 35955459
Anal Chem. 2019 Mar 5;91(5):3459-3466
pubmed: 30707563
Transfusion. 2010 Aug;50(8):1665-76
pubmed: 20158687
J Am Soc Mass Spectrom. 2004 Oct;15(10):1499-508
pubmed: 15465363
Biochemistry. 2000 Oct 31;39(43):13216-22
pubmed: 11052674
J Lipid Res. 1986 Aug;27(8):884-91
pubmed: 3021886
Anal Chem. 2022 Apr 26;94(16):6097-6101
pubmed: 35404045
Biochim Biophys Acta. 1985 Apr 25;834(2):164-71
pubmed: 3995060
J Lipid Res. 2020 Dec;61(12):1539-1555
pubmed: 33037133

Auteurs

Susanne Heimerl (S)

Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93042, Regensburg, Germany.

Marcus Höring (M)

Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93042, Regensburg, Germany.

Dominik Kopczynski (D)

Department of Analytical Chemistry, University of Vienna, Vienna, Austria.

Alexander Sigruener (A)

Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93042, Regensburg, Germany.

Christina Hart (C)

Department of Hematology and Oncology, Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.

Ralph Burkhardt (R)

Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93042, Regensburg, Germany.

Anne Black (A)

Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93042, Regensburg, Germany.

Robert Ahrends (R)

Department of Analytical Chemistry, University of Vienna, Vienna, Austria.

Gerhard Liebisch (G)

Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93042, Regensburg, Germany. gerhard.liebisch@ukr.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH